๐Ÿ•ต๏ธ Bionexus GENE LAB Corp ($BGLC)

SEC insider & ownership activity, last 12 months ยท CIK 1737523 ยท every row links its SEC filing

Insiders were quiet over the last 12 months โ€“ no open-market buys or sells. No red-flag 8-Ks in the window.

Insider flow

0 buyers, $0 (0 lots) ยท 0 sellers, $0 (0 lots)

No open-market insider transactions in the last 12 months.

5%+ holders

No current 5%+ beneficial-ownership positions on file.

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Other events (8.01)Jul 28, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jul 28, 2026 filing โ†—
Other events (8.01)May 29, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 29, 2026 filing โ†—
Reg FD disclosure (7.01)Mar 11, 2026 filing โ†—
Other events (8.01)Mar 11, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Mar 11, 2026 filing โ†—
Other events (8.01)Feb 23, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Feb 23, 2026 filing โ†—
Other events (8.01)Jan 28, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jan 28, 2026 filing โ†—
Shareholder vote (5.07)Dec 24, 2025 filing โ†—
Other events (8.01)Dec 19, 2025 filing โ†—
Material agreement (1.01)Nov 28, 2025 filing โ†—
Unregistered equity sale (3.02)Nov 28, 2025 filing โ†—
Reg FD disclosure (7.01)Nov 28, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Nov 28, 2025 filing โ†—
Material agreement (1.01)Nov 12, 2025 filing โ†—
Unregistered equity sale (3.02)Nov 12, 2025 filing โ†—
Reg FD disclosure (7.01)Nov 12, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Nov 12, 2025 filing โ†—
Material agreement (1.01)Nov 7, 2025 filing โ†—
Reg FD disclosure (7.01)Nov 7, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Nov 7, 2025 filing โ†—
Reg FD disclosure (7.01)Oct 20, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Oct 20, 2025 filing โ†—
Reg FD disclosure (7.01)Jul 30, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Jul 30, 2025 filing โ†—